about us | newsletter | contact | archive | members area
ROBERT NEGOITA, PRESIDENT, ROMANIAN CITIES ASSOCIATION
A quarter of the GDP is produced in Bucharest and the rest goes into the country. That i»
  News:      POLITICS   |   ECONOMICS   |   ENERGY   |   INVESTMENTS   |   APPOINTMENTS   |   GREEN   |   INFRASTRUCTURE   |   REAL ESTATE   |   AGRIBUSINESS   |   DRIVING   |   CITY LIFE   |   EVENTS   |

Cegedim: Pharmaceutical segment in Romania loses 4 per cent in Q1 and reaches 669 million Euro

The pharmaceutical products sales in Romania, reflected in the distribution price decreased by four per cent in Q1 this year compared to the same interval of 2013 and reached a total value of 668.8 million Euro, under expectations, according to Cegedim data.

2014-05-20 10:54:21

Petru Craciun, general manager of Cegedim states that the slightly warmer winter is accountable for the results. For 2014, in the context of a yet not updated subsidized medicine product list, the estimates take into account a decrease from 2.7 per cent to -0.3 per cent in local currency for the market. The decrease in lei for the Q1 was estimated at 1.5 per cent, to 3 billion lei.

In Q1, the pharmaceutical retail segment for Rx products reached 471.7 million Euro (2.12 billion lei), 2.2 per cent less while OTCs accounted for 109 million Euro (490 million lei), increased value of 2.4 per cent. The overall retail decreased in Q1 with 3.9 per cent and reached 580.6 million Euro, while other distribution channels such as hospitals increased with 4.9 per cent to 88.2 million Euro.

The company ranking for this market is led by Servier with 673.3 million lei and increase of 5.8 per cent, Pfizer with 600.1 million lei and 5.1 per cent increase, GlaxoSmithKline (510,3 million lei and 4,4 per cent), Ranbaxy (464,6 million lei and 4 per cent), Merck&Co (450,5 million lei and 3,8 per cent), AstraZeneca (440,3 million lei and 3,8 per cent) and Krka (316 million lei and 2,7 per cent).

They are followed by Johnson&Johnson, Antibiotice, Abbvie, Teva, Menarini, Bayer, Bristol Myers Squibb, Alvogen, Actavis and Eli Lilly, with market shares between 2.5 per cent and 1.6 per cent.



COMMENTS
There are 0 comments:

 
ADD A COMMENT
 
Name
Email
Comment
Validation Code
   
 
 

0 Comments  |  1965 Views
Daily Info
Romania ranks second in region for lowest ratio of companies per 1000 inhabitants

Romania ranks second in Central and Eastern Europe for the lowest ratio of number of companies per 1000 inhabitants, according to a study carried out by Coface Romania regardi...

Enel begins operations at geothermal-hydro power plant in US

Enel S.p.A. ("Enel"), through its subsidiary Enel Green Power North America, Inc. ("EGPNA"), has started operations at an integrated, commercial-scale geothermal-hydro power p...

Survey: Over 60 percent of Romanian employees are happy at the job

Over 61 percent of Romanian employees report being happy at their current job, found a survey conducted by a recruitment company on its website, the company informed in a rele...

PeliFilip assisted Sensiblu in the acquisition of 78 pharmacies belonging to Polisano

PeliFilip assisted Sensiblu and some of its affiliates in the acquisition of 78 pharmacies belonging to Sibpharmamed, part of the Polisano group.

Garanti Bank: GDP growth rate to decelerate next year

Garanti Bank estimates that GDP growth rate could decelerate towards 3.7 per cent next year, as consumption dynamic is expected to revert to pre-stimulus (food VAT cut, as of ...

 
 
   
advertising

advertising

advertising

advertising

advertising

advertising

More on News
Romania takes over rotating presidency of Open Skies Consultative Commission

Romania has taken over the rotating presidency of the Open Skies Consultative Commission (OSCC), and in late September, it chaired the first meeting in a series of four for...

Six companies shortlisted to benefit from state aid for new investment projects

The Finance Ministry has selected six companies out of 36 applicants to grant them state aid for new investment projects that would positively impact the local economy

Providers forced to purchase gas only through the stock exchange

The Romanian Government adopted, in late September, an emergency ordinance governing the obligation of suppliers to purchase gas delivered to domestic customers “on the b...

CTP to invest 250 million Euro in Romania so far

CTP, one of the largest investors and developers of logistics projects in Romania, has invested 250 million Euro on the local market so far, according to a press release is...

Romania’s first residential complex with green energy sold 200 apartments in first phase

Cartierul Solar, the first residential complex with green energy in Romania, located in southern Bucharest and developed by Ad Astra Partners, has completed its first phase...

The government approved the General Masterplan for transport

The government approved in the meeting on Wednesday the General masterplan for transport of Romania, announced Minister of Transport Sorin Buse

Timisoara sees 30-million Euro investment in a new office building project

Werk Property Group, one of the largest real estate developers in Timisoara, will invest 30 million Euro in the development of Vox Technology Park, an A-class office projec...